semaglutide weight loss palm springs Transform Health Creations (@transformhealthcreations) · Delray Beach, FL Meet the team at our

Includes 24/7 support, care coaching, and patient portal tracking tools during treatment

NICE guidance (NG28) recognises GLP-1 receptor agonists as valuable treatment options within the stepped care approach to type 2 diabetes management

Eligibility for the Medicare GLP-1 Bridge will also be limited to Medicare beneficiaries who have not filled a prescription under their Part D plan for a GLP-1 in 2026, and who do not have a diagnosis with a condition that is a medically accepted indication for a GLP-1 drug that could be covered under Part D (specified by CMS as type 2 diabetes, obstructive sleep apnea (OSA), and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH)), even if they otherwise meet the clinical criteria

If you are uncertain whether your plan covers Maximus' services, check with your plan administrator

Certificate of Analysis Every batch independently tested

Brnden A, Albr A, Rohde U, Gasbjerg LS, Rehfeld JF, Holst JJ, et al